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ABSTRACT 
Liver transplantation is the most effective treatment for various end-stage liver diseases. Living donor liver 
transplantation (LDLT) was first developed in Asia due to the severe lack of cadaveric graft in this region. The Liver 
Transplant Service at Queen Mary Hospital (QMH), Hong Kong, has pioneered the application of LDLT to patients 
using both left lobe and right lobe grafts. The QMH liver transplant programme is the largest of its kind in China and 
Southeast Asia. 
Ultrasound (US) is often employed in the initial work-up of potential donor and recipient of LDLT. It is the imaging 
technique of choice to assess the early and late complications of LDLT, with colour Doppler ultrasound being the most 
useful in the evaluation of post-LDLT vascular complications. The use of ultrasound contrast agents improves the 
visualisation of the hepatic vasculature, possibly delaying or removing the need for more invasive investigations. Intra-
operative ultrasound facilitates the determination of the resection plane during donor hepactectomy. 
Computed tomography (CT) or magnetic resonance imaging (MRI) can be used as the single imaging modality in 
the evaluation of LDLT candidates. 
Ultrasound is most useful as the initial screening test in detecting hepatic parenchymal abnormalities, while CT or 
MRI is the modality of choice in the demonstration of vascular and biliary anatomy of the potential liver donor.  
Biliary complications are more common in LDLT than in cadaveric liver transplantation. The ductal dilatation, 
resulting from biliary stricture, is clearly demonstrated by ultrasound. Bilomas can be aspirated under ultrasound 
guidance to confirm the diagnosis and to promote healing. Perihepatic fluid collections and abscesses are also common 
after LDLT. Intra-hepatic collections may represent seromas, haematomas or infarction. Ultrasound is a sensitive means 
of detecting these collections and can be employed to guide drainage in suitable patients. 
Transplant-related malignancies include recurrent neoplasia and post-transplant lymphoproliferative disease 
(PTLD). Ultrasound can be used to screen for recurrent disease and to detect PTLD in the transplanted liver. © 2006 
Biomedical Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
Liver transplantation is the most effective treatment 
for various end-stage liver diseases and sudden, acute 
liver failure. Due to the worldwide shortage of cadaveric 
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liver, innovative surgical techniques, including split liver 
transplantation and living donor liver transplantation 
(LDLT), have been developed. LDLT was first initiated 
in Asia to address the severe lack of cadaveric graft in 
this region. Over 12 years, more than 1500 cases of 
LDLT have been performed in five Asian centres (Kyoto, 
Tokyo, Asan, Hong Kong, Taiwan) with 1- and 5-year 
actuarial patient survival rates of 78.7%-97.8% and 
76.1%-97.8% being achieved, respectively [1].  
The Liver Transplant Service at Queen Mary 
Hospital (QMH), Hong Kong, has pioneered the 
application of LDLT to patients using both left lobe and 
right lobe grafts. The QMH liver transplant programme 
is the largest of its kind in China and Southeast Asia. By 
the end of December 2003, a total of 321 liver 
transplants (210 right lobe LDLT) were performed with 
1-year and 5-year survival rates of 84% and 79%, 
respectively. Successful transplantation requires a 
detailed evaluation of the transplant candidate and the 
potential living donor.  
Imaging has contributed to the development and 
success of LDLT in the selection of patients as well as 
detection and management of post-transplant 
complications. The use of ultrasound in the evaluation of 
LDLT patients and assessment of the post-operative 
complications is discussed in this review. 
I. PRE-TRANSPLANT ASSESSMENT 
Evaluation in recipients 
Pre-transplant imaging plays an important role in 
identifying contraindications to transplantation, anatomic 
abnormalities and variants that may alter the surgical 
approach. 
i) Liver parenchyma 
Ultrasound may show changes of cirrhosis with 
nodular contours, parenchymal inhomogeneity, right- 
lobe atrophy and hypertrophy of lateral segment and 
caudate lobe [2].  
Cirrhosis often causes narrowing of the hepatic 
veins with loss of the normal phasic waveform. Intra-
hepatic vessels may be indistinct. The caudate lobe can 
become enlarged and surround the inferior vena cava 
(IVC), which is of relevance in cases of living donor 
transplantation in which IVC is preserved.  
Colour Doppler ultrasound may show portal vein 
flow reversal or portal collaterals, suggesting the 
diagnosis of portal hypertension.  
ii) Presence and extent of hepatocellular carcinoma 
Liver transplantation for the treatment of 
hepatocellular carcinoma (HCC) provides excellent 
outcomes with application of the Milan criteria (single 
nodule < or = 5cm, or two or three nodules < or = 3cm) 
with 5-year survival rates of 70% and low recurrence 
rates [3].  
A recent study has suggested that currently available 
selection criteria for HCC patients can be applicable to 
LDLT without change of prognostic power [4]. 
Ultrasound is often used to screen HCC in a high 
risk population. Contrast enhanced ultrasound greatly 
increases the sensitivity in the detection of HCC (Figure 
1) [5].  
Accurate radiological staging is required to define 
suitable HCC candidates for liver transplantation. While 
either computed tomography (CT) or magnetic resonance 
imaging (MRI) can be used, many studies have found 
MRI to be superior to detect and characterise focal 
hepatic lesions [6]. 
iii) Presence of cholangiocarcinoma and other 
malignancies 
Known cholangiocarcinoma is a contraindication to 
liver transplantation due to a high recurrence rate. The 
detection of an extra-hepatic tumour with or without 
hepatic metastasis also excludes the patient from 
transplantation. Ultrasound evaluates the intrahepatic 
tumour. Both CT and MRI can also be used to depict 
extra-hepatic disease in patients with malignancy, with 
studies showing MRI to be superior to helical CT in this 
regard [7]. 
iv) Patency of the portal vein and superior mesenteric 
vein 
Diffuse thrombosis of the portal and superior 
mesenteric vein (SMV) is a contraindication to liver 
transplantation. Portal vein thrombosis requires the 
modification of surgical technique at the time of 
transplantation. Ultrasound can be used to assess the 
vascular patency of a potential transplant recipient. 
Contrast enhanced ultrasound improves the colour and 
spectral Doppler signal, thereby increasing operator 
confidence. However, ultrasound evaluation of the SMV 
patency remains problematic because of overlying bowel 
gas. Contrast enhanced CT or MRI/MRA (magnetic 
resonance angiography) can be employed to evaluate the 
patency of these vessels. 
v) Celiac artery stenosis 
Recipients with celiac artery stenosis are at risk of 
compromised blood flow to the transplanted organ. 
Doppler ultrasound has high accuracy in the diagnosis of 
high grade splanchnic arterial stenosis, and can be used 
as a screening method for celiac artery stenosis [8].  
Computed tomography angiography (CTA) is an 
established method to evaluate arterial anatomy, 
aneurysm and stenosis [9].  
Narrowing, mural thrombus and post-stenotic 
dilatation can be demonstrated with CTA. Contrast 
enhanced MRA is the alternate means of assessing these 
abnormalities. The detected stenosis is corrected at 
surgery.  
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Figure 1  Hepatocellular carcinoma (HCC) in a 75 year old woman. (a) Baseline US showed a hypoechoeic lesion 
at the right hepatic lobe. (b) Dynamic contrast enhanced US with SonoVue. The early arterial phase 
image demonstrated peripheral tumoural vessels (arrows) with enhancement filling from the periphery. 
(c) The arterial phase image showed homogeneous tumoural enhancement with a small hypoechoic area 
(arrow). (d) In the portal phase, the HCC (arrows) became relatively hypoechoic to the surrounding 
enhanced liver parenchyma. 
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Figure 2  Hepatic artery thrombosis after LDLT. (a) Colour Doppler US showed patent coeliac artery (arrow). (b) 
Absence of flow and Doppler signal seen at the expected location of the hepatic artery (arrow). PV: 
Portal vein. (c) Digital subtraction angiogram of the coeliac axis confirmed thrombosis of the hepatic 
artery (arrow). 
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vi) Status of transjugular portosystemic shunt 
Some recipients may have undergone placement of a 
transjugular portosystemic shunt (TIPS) prior to 
transplantation. The patency of the shunt can be assessed 
with colour Doppler ultrasound, including Power 
Doppler. The use of ultrasound contrast readily 
establishes the patency of the stent. Migration of the 
shunt and shunt related stenosis could affect 
transplantation in a significant number of patients. The 
location of the proximal and distal ends of the shunt can 
easily be determined by CT. However, MRI evaluation 
of graft patency may be limited by metallic stent artefact.  
Evaluation in liver donors 
In addition to detailed clinical examination, 
informed consent with the surgical team, 
cardiopulmonary function assessment and numerous 
laboratory and serologic tests, the potential living donor 
has to undergo extensive imaging evaluation to identify 
exclusion criteria for liver donation and obtain necessary 
information to ensure success in transplantation.  
i) Hepatic artery anatomy to the graft lobe 
Detailed anatomic information is required to plan 
the hepatic-arterial, portal-venous and hepatic-venous 
surgical anastomosis in LDLT. Hepatic angiography is 
the traditional gold standard in the preoperative 
assessment of the vascular anatomy of potential liver 
transplant patients. Multi-detector computed tomography 
(MDCT) or contrast-enhanced MRI can be used as a 
non-invasive alternative (10, 11, 12). 
Intra-operative ultrasound is performed to direct 
hepatic transection in an avascular plane during donor 
hepactectomy.  
The disadvantages of CT include the use of ionising 
radiation and injection of potentially nephrotoxic 
iodinated contrast.  
ii) Venous and biliary anatomy 
The main branches of the hepatic vein drain into the 
inferior vena cava. The portal vein usually bifurcates into 
the left and right portal veins, which are easily 
demonstrated by Doppler ultrasound. The main portal 
vein may “trifurcate” with an early branching pattern in 
the right hepatic lobe. Accessory right hepatic veins 
occur in 6% of people and can cause increased bleeding 
if unrecognised before surgery.  
Venous anatomy is well demonstrated by contrast 
enhanced CT or MRI/ MRA. 
The biliary system can be evaluated with endoscopic 
retrograde cholangiopancreatography (ERCP), CT 
cholangiography [13] and MR cholangiography (MRC). 
MRC, utilising heavily T2W pulse sequences, accurately 
depicts biliary anatomy in potential LDLT donors and 
guides the intra-operative management of the biliary tract 
[14].  
 MRC, enhanced with hepatobiliary agent, is highly 
accurate in demonstrating the biliary anatomy in adult 
living liver donors [15]. 
iii) Liver volume 
The success of LDLT depends on adequate graft 
volume. The volumes of potential donor livers are 
matched with the volume needed by the recipient, as 
calculated according to body surface area. A minimum of 
40% of the normal liver volume is required by the 
recipient [16]. At least 30% of the liver should be left in 
the donor [17].  
Both CT and MRI can be used to calculate the graft 
and remnant liver volume. CT provides accurate and 
reproducible estimate of liver graft mass. Besides hepatic 
volume determination, MRI can also estimate the degree 
of fatty infiltration and evaluate the vascular and biliary 
anatomy, without the risk of ionising radiation.  
iv) Liver parenchyma 
An important donor-related risk factor, associated 
with poor recipient outcome after orthotopic liver 
transplantation, is moderate- to severe donor steatosis.  
Ultrasound, CT and MRI are useful to evaluate focal 
hepatic lesions detected in asymptomatic potential 
donors. 
Ultrasound easily detects the presence of fatty 
infiltration. Severe fatty infiltration often results in an 
enlarged liver with diffuse increase echogenicity [2]. 
Acoustic penetration may be reduced with 
indistinctness of the blood vessels and the diaphragm. 
Quantification of the degree of fatty infiltration may be 
accomplished with dual energy CT.  
Opposed-phase gradient echo MRI can be 
performed to provide an objective estimate of the degree 
of hepatic steatosis. Donor hepatic biopsy is performed 
in some institutions to accurately assess the degree of 
steatosis. 
 
II. INTRA-OPERATIVE EVALUATION 
Intra-operative ultrasound is used to determine the 
optimal plane of resection during LDLT. The donor liver 
must be divided along a plane that avoids major vessels, 
while leaving both donor and recipient with sufficient 
liver volume for proper function. The optimal resection 
plane is about 1 cm to the right of the middle hepatic 
vein [18]. 
Our Centre now employs the hepatic venoplasty 
technique to facilitate the implantation of the right lobe 
graft and quarantines flow in the middle hepatic vein 
[19].  
Intra-operative ultrasound is most useful to depict 
venous anatomy for the surgeon. The hepatic vein 
branches, from segment V and VIII, that drain into the 
right hepatic vein are identified by ultrasound and 
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Figure 3  Hepatic artery stenosis after liver transplantation with cholangitic abscess. (a) Colour Doppler US at 
post-stenotic segment of hepatic artery showed turbulent flow and elevated peak systolic velocity. (b) 
Tardus-parvus waveform at pre-stenotic segment of hepatic artery with dampened flow. (c) Hypoechoic 
cholangitic abscess at right lobe liver graft due to hepatic ischaemia (arrows). 
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Figure 4  Hepatic artery pseudo-aneurysm after LDLT. (a) Doppler US detected roundish hypoechoic lesion close 
to hepatic artery (arrow). Spectral Doppler demonstrated elevated peak systolic velocity at neck of 
pseudo-aneurysm. (b) Colour Doppler US revealed turbulent flow within the lesion (arrows). HA: 
Hepatic artery, PV: Portal vein. (c) Contrast enhanced CT showed pseudo-aneurysm (arrows). (d) 
Digital subtraction angiogram of celiac axis demonstrated pseudo-aneurysm (arrows). 
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Figure 5  Hepatic vein stenosis after LDLT. (a) US showed stenosis of the hepatic vein (arrow). IVC: Inferior 
vena cava. (b) Colour Doppler US demonstrated elevated velocity. 
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marked, because these vessels will be divided during 
donor hepatectomy [20].  
Accessory hepatic veins can also be identified by 
ultrasound. The right portal vein should not be divided 
too close to the portal vein bifurcation, otherwise a 
stenosis will be created [21].  
Ultrasound can be used to identify the origin of the 
right portal vein during right lobe resection. Intra-
operative Doppler ultrasound also helps detect abnormal 
hepatic hemodynaemics, allowing early intervention to 
ensure better patient outcome (22, 23). 
III. NORMAL ULTRASOUND APPEARANCE OF LIVER 
TRANSPLANTS 
A routine post-operative ultrasound of the 
transplanted liver includes grey-scale assessment of the 
liver parenchyma and biliary tree and Doppler study of 
the hepatic vasculature. The normal portal vein Doppler 
waveform is a continuous flow pattern toward the liver 
with mild velocity variations induced by respiration. The 
normal Doppler appearance of the hepatic veins and IVC 
shows a phasic flow pattern.  
The normal graft liver has a homogeneous or 
slightly heterogeneous pattern at grey-scale imaging [24]. 
The intrahepatic biliary ducts should be of normal caliber 
and appearance. In the early post-operative period there 
is usually a small amount of perihepatic fluid. The 
normal hepatic artery Doppler waveform shows a rapid 
systolic up-stroke with continuous diastolic flow. The 
acceleration time should be less than 80 msec, and the 
resistive index (RI) should be between 0.5 and 0.7 [24].  
High-resistance flow at the hepatic artery detected 
on Doppler ultrasound during the period immediately 
after transplantation is a frequent finding and has no 
prognostic implication [25]. 
IV. EVALUATION OF POST-LDLT COMPLICATIONS 
Despite the rapid advances in surgical techniques 
and improvements in immuno-suppression, various 
complications still occur after LDLT, resulting in 
significant patient morbidity and mortality (1,26,27) 
(Table 1).  
Ultrasound is the initial imaging technique of choice 
to assess the early and late complications of LDLT. The 
examination can be easily performed at the bedside and 
repeated to follow up detected abnormalities. Most 
transplant centres, including ours, employ colour 
Doppler ultrasound in the peri- and post-operative period 
for assessing the patency of the hepatic artery, hepatic 
veins and portal veins to ensure proper functioning of the 
liver graft.  
Helical computed tomography (CT) is a valuable 
complement to ultrasound in the post-operative period 
and is a safe, accurate and non-invasive means of 
detecting post-operative complications [28].  
Recipient post-LDLT complications 
i) Acute rejection 
Acute rejection is the most common and most 
serious complication affecting graft survival. The 
incidence of acute rejection ranges from 17% to 40% and 
is lower than that of cadveric liver transplantation with 
unknown reason [1]. 
Unfortunately, no imaging modality has proved 
sensitive or specific for the diagnosis of rejection. The 
only reliable means of diagnosis is by graft biopsy and 
histologic study [29]. 
Imaging studies, including ultrasound, can be used 
to rule out other complications that have similar clinical 
signs and symptoms to acute rejection. Ultrasound or CT 
is occasionally used to guide percutaneous biopsy of the 
liver graft to confirm the occurrence of acute rejection. 
ii) Vascular complications 
Vascular complications are reported in about 9% of 
liver transplant patients and are the most common 
significant post-operative complications. Post-LDLT 
vascular complications include thrombosis and stenosis 
of the hepatic artery, hepatic veins and portal veins as 
well as pseudoaneurysm formation. Vascular problems 
appear to be more common in the paediatric group of 
LDLT patients and are most likely due to the small size 
of vessels and technical factors [1].  
Colour Doppler ultrasound is used as the main 
screening technique, while angiography is reserved for 
confirming ultrasound findings or when ultrasound 
findings are equivocal. Doppler spectral waveform 
analysis provides excellent screening for the detection of 
hepatic allograft arterial stenosis or thrombosis [30]. 
The use of ultrasound contrast agents improves 
visualisation of the hepatic vasculature and shortens the 
examination time, possibly delaying or obviating the 
need for more invasive investigations [31].  
Excellent results have been reported using multi-
slice CT angiography in detecting vascular complications 
after liver transplantation [32]. Contrast MRA is another 
alternative non-invasive technique for this purpose [33]. 
Hepatic artery thrombosis is the most common 
vascular complication of liver transplantation. Treatment 
requires urgent revascularisation or retransplantation. 
The diagnosis is established when colour Doppler 
ultrasound fails to identify both an arterial colour 
Doppler signal and waveform along the anticipated 
course of the hepatic artery (Figure 2).  
Protocol Doppler ultrasound with RI measurement, 
during the first two weeks after LDLT, is found to 
predict hepatic artery thrombosis [34].  
The use of contrast enhanced colour Doppler 
ultrasound may increase the confidence in excluding 
arterial thrombosis [35].  
Definitive diagnosis is by angiography. Contrast-
enhanced CT or MRI helps in defining the degree of 
parenchymal ischaemia in these patients. Geographic 
areas of decreased echogencity, with preservation of the 
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Figure 6  Portal vein stenosis after LDLT with subphrenic collection. (a) US showed stenosis of the portal vein 
anastomosis (arrow). (b) Colour Doppler US revealed elevated velocity. (c) Subphrenic collection also 
detected by US (arrows). 
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Figure 7  Ductal calculi after LDLT due to biliary stenosis. (a) US showed echogenic ductal calculi at right lobe 
graft (arrows). (b) Non-contrast CT confirmed hyperdense ductal stone (arrow). 
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portal tracts, are the early sonographic signs of hepatic 
ischaemia [36].  
Ultrasound with microbubble contrast enhancement 
may also provide confirmation of areas of infarction. 
The presence of a tardus-parvus waveform pattern in 
the Doppler ultrasound is suggestive of hepatic artery 
stenosis (Figure 3) [37].  
Contrast-enhanced ultrasound can easily 
demonstrate focal stenosis at the hepatic arterial 
anastomosis. Angiography with a view to angioplasty 
can then be performed. Balloon dilatation of a stenosis is 
frequently successful, obviating the need for further 
surgery and vascular reconstruction. Coronary stents may 
also be used [38]. 
Hepatic artery pseudoaneurysm is rare after liver 
transplantation and occurs in 1% of patients. It may be 
intra- or extra-hepatic in location. 
Ultrasound is the primary technique for detection, 
but it may also be seen on contrast-enhanced CT or MRI. 
Colour Doppler ultrasound shows a high velocity jet with 
a swirling pattern of flow within the cavity (Figure 4). 
Treatment is by surgery, coil embolisation or 
percutaneous thrombin injection [39]. 
A persistent monophasic wave pattern on Doppler 
ultrasound images of the hepatic veins is suggestive of 
substantial hepatic vein stenosis after LDLT (Figure 5) 
[40]. A persistent triphasic wave pattern on Doppler 
ultrasound images can exclude the possibility of 
substantial stenosis.  
Hepatic vein complications, including thrombosis 
and stenosis, occur in 1.9% of our patients (Table 1). 
Hepatic vein thrombosis appears as absence of flow on 
colour Doppler ultrasound, and echogenic thrombus may 
be seen within the hepatic vein. Ultrasound with 
microbubble contrast-enhancement is capable of 
demonstrating vascular outflow abnormalities of the 
hepatic veins and IVC when standard colour Doppler 
examination is difficult or the result is equivocal [31]. 
Portal vein abnormalities are uncommon and occur 
in 1% to 3% of transplant recipients. Acute portal vein 
thrombus appears moderately hypoechoic or isoechoic 
with absence of Doppler signal [20]. Partial obstruction 
of the portal vein may be caused by thrombus or stenosis 
at the portal vein anastomosis (Figure 6). Diffuse low 
velocities in the portal vein or focally elevated velocities 
at the anastomosis are signs of portal vein stenosis. 
Transhepatic portal venoplasty or stent insertion may be 
performed in significant portal vein stenosis.  
iii) Biliary complications 
Bile duct complications are a significant cause of 
post-transplant morbidity and mortality [1], occurring in 
24% of our liver transplant recipients (Table 1). Biliary 
complications are more common in LDLT than in 
cadveric liver transplantation [41] and include bile leaks, 
strictures, calculi (Figure 7) or sludge and dysfunction of 
sphincter of Oddi.  
Bililary strictures are more frequent in adult LDLT 
patients probably due to higher incidence of multiple 
ducts in right lobe grafts [1]. Percutaneous transhepatic 
cholangiography or endoscopic retrograde 
cholangiography is used to diagnose biliary stricture and 
bile leak. MRC has been found to be a reliable technique 
for detecting post-orthotopic liver transplanatation biliary 
complications [42]. 
Bile leak is caused by technical failure at the duct-
to-duct or biliary-enteric anastomosis, and by hepatic 
artery thrombosis at non-anastomotic sites. Biliary 
obstruction can be divided into anastomotic and non-
anastomotic strictures with causes due to technical 
failure, ischemia, calculi, mucocele of the cystic duct 
remnant and recurrent malignancy.  
Biliary-enteric anastomosis is performed in many 
LDLT with the segmental ducts individually 
anastomosed to a small bowel loop. Anastomotic 
stenosis can lead to obstruction of a segmental hepatic 
duct. The ductal dilatation, resulting from biliary 
stricture, is easily demonstrated by ultrasound. Stricture 
of the bile duct anastomosis is diagnosed by direct 
cholangiography, either endoscopic for end to end biliary 
reconstruction or percutaneous for Roux loop biliary 
reconstruction.  
MRC has a role in non-invasive demonstration of 
the stricture, reserving the invasive techniques for when 
intervention is necessary. Treatment is by percutaneous 
or endoscopic dilatation with temporary stenting, while 
surgery is reserved for recurrent strictures or those not 
responding to the less invasive measures. 
Bilomas can be aspirated under ultrasound guidance 
to confirm the diagnosis, promote healing and preserve 
graft integrity (Figure 8) [43]. Should direct 
cholangiography confirm a bile leak, then anastomotic 
stenting may be performed if the integrity of the hepatic 
artery has been established. Radionuclide (Tc 99m HIDA) 
and MRC are alternative tools in detecting bile leak. 
Volumetric mangafodipir-enhanced cholangiography 
provides satisfactory evaluation of intra-hepatic biliary 
anatomy. MR evidence of bile leakage is well 
demonstrated after intravenous infusion of the MR 
hepatobiliary contrast agent, mangafodipir [44]. 
iv) Post-operative collections 
Perihepatic fluid collections and abscesses are not 
uncommon after LDLT. Intra-hepatic collections appear 
as cystic or solid masses without internal vascularity and 
may represent seromas, haematomas or infarction [20].  
Complex lesions with mass effect on surrounding 
structures are suggestive of hematomas. Ultrasound 
detects these collections and can be used to guide 
percutaneous drainage in suitable patients. 
 v) Infections 
Infections remain the most significant causes of 
morbidity in patients undergoing LDLT [1], with 
immuno-suppression being the most critical predisposing 
factor. Prophylactic regimens vary among transplant 
centres, but some success can be achieved in reducing 
the prevalence and severity of peri-operative or long 
term infections by various viral, fungal, protozoan, 
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Figure 8  Biloma after LDLT diagnosed by US guided aspiration. (a) Hypoechoic collection detected by US at 
right lobe (arrows). (b) Tip of needle (arrow) during US guided aspiration (arrow). (c) Post-aspiration 
US showed marked decrease in size of biloma (arrows). 
 
 
 
(a) 
 
 
(b) 
 
Figure 9  Post transplant lymphoproliferative disease after LDLT. (a) US showed hypoechoic lesion at right lobe 
graft (arrows). (b) Contrast enhanced T1W MR image revealed hypovascular tumours (arrows). 
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Figure 10 Recurrent hepatocellular carcinoma (HCC) after LDLT. (a) US detected large heterogeneous lesion at 
liver graft (arrows). (b) Contrast enhanced arterial CT image showed multifocal HCC recurrence. 
 
 
 
 
 
Table 1  Complications of liver transplantation at Queen Mary Hospital, Hong Kong (October 1991-December 
2003) 
Major complication  Percentage  Number of patients 
n = 321 
Delayed graft dysfunction  0.3%  1 
Primary non-function  0.6%  2 
Post-transplant lymphoproliferative disease  1.9%  6 
Graft versus host disease  0.6%  2 
Hepatic vein stenosis/ thrombosis  1.9%  6 
Hepatic artery thrombosis  2.2%  7 
Portal vein thrombosis  6.9%  22 
Biliary leakage  6.2%  20 
Intraabdominal haemorrhage  7.5%  24 
Biliary stricture  17.8%  57 
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bacterial and mycobacterial agents. Serologic 
examinations and bacterial investigations of blood, 
sputum, stool, urine and discharge from drains, as well as 
antibiotic sensitivity tests, should be performed when 
necessary. 
vi) Post-transplant malignancies 
Approximately 4-5% of liver transplant recipients 
develop malignant tumours with a four fold increase in 
the incidence of lymphoma when compared with the 
general population. The majority of these tumours are 
non-Hodgkin’s lymphoma. Imaging evaluation and 
treatment of these diseases follow the principles of 
accepted oncological staging criteria.  
Post-transplant lymphoproliferative disease (PTLD) 
represents a spectrum of B-cell proliferation ranging 
from lymphoma to a mononucleosis-like disease. They 
are found almost exclusively in the paediatric group of 
LDLT patients [1], and 1.9% of our liver transplant 
patients are affected (Table 1).  
Imaging features are often non-specific and 
definitive diagnosis requires biopsy [45]. Ultrasound 
may reveal hypoechoic, poorly vascularised solid masses 
in the liver of PTLD patients in addition to the finding of 
para-aortic lymphadenopathy (Figure 9) [20].  
The use of LDLT in the management of HCC 
remains controversial. Patients transplanted for HCC are 
at risk of recurrent disease, with the most frequent sites 
being the lung and the liver allograft (Figure 10) [46]. 
Ultrasound can be used to screen these patients and 
contrast-enhanced ultrasound may increase confidence in 
difficult cases. Contrast CT or MRI is also effective in 
the detection of these recurrent tumours. 
Donor post-LDLT complications 
The overall donor complication rate for 1,508 LDLT 
performed in five Asian transplant centres was reported 
to be 15.8%, and 1.1% of donors underwent re-
laparotomy [47].  
The complication rate was higher in right lobe than 
left lobe donors.  
More serious complications also occurred in right 
lobe donors and included cholestasis, bile leakage, 
biliary stricture, portal vein thrombosis, intra-abdominal 
bleeding and pulmonary embolism [47].  
Radiological work-up follows the accepted imaging 
criteria. The long term outcome of liver donation remains 
unknown and transplant centres should continue their 
follow-up of donors. 
SUMMARY 
Living donor liver transplantation (LDLT) provides 
a valuable alternative to cadaveric liver transplantation in 
the treatment of acute fulminant liver failure and various 
end-stage liver diseases.  
Ultrasound is the imaging modality of choice in the 
initial evaluation of both donor and recipient before and 
after LDLT. 
Despite rapid advances in surgical techniques and 
improvement in immuno-suppression, significant 
complications still occur after LDLT.  
Colour Doppler ultrasound is most useful in the 
evaluation of post-LDLT vascular complications, while 
cholangiography is required in the diagnosis of biliary 
complications.  
The knowledge of normal and abnormal ultrasound 
findings after LDLT is essential for the early detection of 
post-LDLT complications, permitting timely intervention 
and ensuring optimal outcome in these patients. 
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